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Abstract 
BACKGROUND: It is assumed that the occurrence of keratinocyte and melanocytic tumours is multifactorial 
driven. Certain risk factors such as solar radiation, p53 protein and Melanocortin-1 receptor (MC1R) prove to be 
common to their development, which at the same time shows that their simultaneous manifestation in the same 
patients, for example, is quite possible. Such a manifestation could be observed as collision tumours within the 
same solitary lesion or as a simultaneous occurrence within two completely different lesions that are clearly 
distinguished from one another. 
CASE REPORT: An 85-year-old patient is presented with three primary cutaneous tumours located in region 
presternal, infraorbital sinistra and scapularis extra. The lesions were removed during a single surgical session. 
For the high-risk basal cell carcinoma (BCC) in the lower eyelid, the so-called melolabial advancement flap was 
applied, and for the tumours located in the other two areas, the undermining surgical approach was applied. The 
subsequent histological analysis found that the case referred to two keratinocyte tumours (BCC) and one 
melanocyte tumour (cutaneous melanoma). 
CONCLUSIONS: The patient presented is interesting with regard to 1) the simultaneous presentation of three 
primaries with different localization (so far not described in the world literature, namely 2 basal cell carcinomas 
and one melanoma in the same patient concurrently), 2) one of the basal cell tumours belongs to the group of 
high-risk (according to the localization) and meanwhile advanced BCC (according to the infiltration degree of the 
underlying tissue-infiltration of the musculature) and 3) their simultaneous successful surgical treatment in a single 
surgical session under local anaesthesia. 
 
 
 
 
 
 
 
Introduction 
 
Solar radiation could be considered a major 
etiologic/risk factor for the occurrence of basal cell 
carcinoma and malignant melanoma [1], [2]. The 
combination of mutations in the p53 gene and UV 
radiation increases the risk of development of 
melanoma and non-melanoma skin tumours [3], [4]. 
There are some regulatory proteins that may prove to 
be key but also common for the development of both 
melanomas and basal cell carcinomas [5], [6] [7], [8].  
For example, the p53 protein and 
Melanocortin-1 receptor (MC1R) are considered as 
risk factors for both malignant melanoma (MM) and 
basal cell carcinoma (BCC), as well as for 
spinocellular carcinoma (SCC) development [5] [6] [9]. 
These data allow us to conclude that the simultaneous 
manifestation of melanocytic and keratinocyte 
cutaneous tumours should be entirely possible [10] 
[11]. 
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Case report 
 
An 85-year-old patient is presented with some 
concomitant diseases: arterial hypertension, chronic 
congestive heart failure, high grade aortic, mitral and 
tricuspid insufficiency, atrial fibrillation, pulmonary 
hypertension, cholelithiasis, hiatal hernia, iron 
deficiency anaemia and idiopathic thrombocytopenia. 
Treatment with Eltrombopag (25 mg x 1/day) is given 
with good results for idiopathic thrombocytopenia. The 
patient was hospitalised for scheduled surgical co-
removal of the tumour formations located in the lower 
eyelid, back and sternum. During the dermatological 
examination, three lesions of different nature and 
localisation were identified. In the region pre sternalis 
a pigmentary lesion with irregular edges, clinically and 
dermatoscopically suspected for melanoma, was 
identified (Figure 1d and 1e). In the area, scapularis 
extra, an exophytic oval tumorous formation with an 
ulcerative and at the same time heavily bleeding 
surface, with a diameter of approximately 6-7,8 cm, 
was additionally noted (Figure 1a). In regio 
infraorbitalis sinistra, immediately next to the lower 
eyelid, an exophytic tumorous formation with a 
centrally located erosive surface covered with 
hemorrhagic crusts and a slightly raised peripheral 
edge were observed (Figure 1b and 3a). Surgical 
removal of the three formations was planned under 
local anaesthesia within one surgical session. The 
lesion located in regio presternal, suspected for 
malignant melanoma, was removed by elliptical 
excision under local anaesthesia, with a surgical 
safety margin of 0.5 cm in all directions (Figure 1f). 
The resulting surgical defect was closed by single 
interrupted stitches (Figure 1g).  
 
Figure 1: a) Clinical view of the lesion in regio scapularis extra-
exophytic oval tumorous formation with ulcerative and at the same 
time heavily bleeding surface, with a diameter of approximately 7/8 
cm; b) Exophytic tumorous formation with a centrally located 
erosive surface covered with hemorrhagic crusts and a slightly 
raised peripheral edge in regio infraorbitalis sinistra; c) 
Simultaneous clinical view of the three lesions during the first 
dermatological examination; d) Regio pre sternalis-pigmentary 
lesion with irregular edges; e) Preoperative outlining of the 
pigmentary lesion surgical margins; f) Intraoperative finding-elliptical 
excision of the melanocytic lesion; g) Postoperative view following 
the removal of the melanocytic lesion-closure of the defect with 
single interrupted stitches 
 
The histological analysis showed that it was 
malignant melanoma, superficial progression type, III 
Clark’s level, 2 mm Breslow’s thickness, no ulceration, 
high mitotic activity, abundant lymphocytic infiltration 
in the stroma, no spontaneous regression, clear 
resection lines, IB (T2aNxM0) stage. 
The lesion localised in regio scapularis extra, 
suspected for spinocellular carcinoma, was removed 
by extensive elliptic excision under local anaesthesia 
(Figures 2b, 2c and 2d). This was followed by careful 
dissection of the subcutaneous tissue to the muscles 
in all directions to a better adaptation of the wound 
edges (Figure 2e). The resulting surgical defect was 
recovered by stretch plastics (Figure 2f). The 
histological analysis found that it was a basal cell 
carcinoma with clear resection lines, I stage. The 
tumour formation in the area of regio infraorbitalis 
sinistra, which was the cause of hospitalisation and 
suspected for basal cell carcinoma, was surgically 
removed in stages by melolabial advancement 
plastics.  
 
Figure 2: a) Preoperative view of the lesion in the shoulder area-
disinfection; b), c), d) and e) Intraoperative view-elliptical excision of 
the exophytic lesion in regio scapularis extra; f) Postoperative 
closure of the surgical defect by stretch plastics and single 
interrupted stitches 
 
The lesion was initially contoured with a 
surgical safety margin of 0.2-0.3 cm medially to the 
nose, laterally to the ear and caudally to the upper lip, 
and cranially due to the proximity to the lower eyelid, 
with a distance of approximately 0.1 cm (Figure 3a). In 
the second stage, the lesion was excised in the form 
of a quadrangle with oval edges, and a small part of 
the underlying muscle was also removed (Figure 3b 
and 3c). After stopping the bleeding, the skin integrity 
in the area of the resulting skin defect was restored by 
a melolabial advancement flap. Expansion of the 
defect was initiated by conducting an initial single 
oblong incision parallel to the melolabial fold, followed 
by skin erosion laterally to the incision and finally 
transposition of the skin upward using slight rotation 
(Figure 3d). The transposition flap was carefully 
adapted to the edge of the lower eyelid by single 
subcutaneous stitches, and then by skin stitches 
(Figure 3e and 3f). Histological verification showed 
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that it was an advanced high-risk basal cell carcinoma 
with clear resection lines, II stage. 
 
Figure 3: а) Preoperative outlining of the safety surgical margins; b), 
с) Oval excision of the lesion located in regio infraorbitalis sinistra; 
d) Intraoperative finding-stopping the bleeding by electrocautery; е) 
Postoperative view after the melolabial advancement flap; d) 
Clinical postoperative status-single interrupted stitches 
 
At the time of the surgical intervention, there 
was no apparatus or laboratory evidence of 
progression of both melanoma and the keratinocyte 
tumours. 
About the histologically established 
melanoma, it was recommended to perform a re-
excision with safety surgical margin of 1.5 cm within 
14 days, and detect the draining lymph node within 
the same surgical session. 
 
 
Discussion 
 
About the BCC and MM occurrence, UV 
radiation is referred to as an exogenous etiological 
factor of paramount importance [1], [2]. In turn, a large 
number of regulatory proteins are considered to be 
the key endogenous factors in the pathogenesis of 
melanoma and non-melanoma skin tumours [5], [6], 
[7], [8]. P53 protein and Melanocortin-1 receptor 
(MC1R) are identified as risk factors for the 
development of malignant melanoma (MM), basal cell 
carcinomas (BCC) and spinocellular carcinomas 
(SCC) [5], [6], [9]. P53 gene mutations lead to 
overproduction of long-life mutant forms of p53 
protein, which in combination with the additional 
influence of sunlight significantly increases the risk of 
developing BCC and malignant melanoma [3], [4]. 
Similar dependence is seen with combined UV 
radiation and various gene variants of the 
Melanocortin-1 receptor (MC1R) [5], [6]. These 
common risk factors and mechanisms in the genesis 
of melanocytic and keratinocyte tumors suggest their 
possible simultaneous presentation in the same 
patient [1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], 
[12]. 
The simultaneous manifestation of 
melanocyte and keratinocyte skin tumours may be 
seen in the form of the so-called 1) collision tumours – 
when they are established within the same lesion 
(clinically, dermatoscopically and/or histologically) and 
2) simultaneous occurrence of two or more 
histologically distinct primary malignancies [12], [13]. 
The presence of two different malignant tumours at 
the same time, located within the same histological 
sample, is referred to as the so-called collision 
tumours [14], [15]. However, depending on the 
boundaries between cells, the simultaneous 
manifestation of two histologically distinct tumours is 
subdivided into two types: 1) collision type, in which 
each cellular type is distinct, and 2) intermingled type, 
in which the two cell types are “intimately related” [16]. 
The predominant number of documented cases in the 
world literature represents the BCC and MM 
combination [12], [14], [15], [16]. In this respect, their 
correlation is interesting, defined as parasitism, i.e. 
BCC colonization by MM [14], [17], [18], [19]. A two-
phase and three-phase manifestation in the form of a 
squamomelanocytic tumour, basomelanocytic tumour 
or basosquamous melanocytic malignant tumour [20], 
[21], [22] is also possible, though relatively rare. Even 
in the form of a collision tumour, the ability of the 
malignant melanoma to provide metastasis is retained 
[15], [23]. In some cases, metastasis may manifest as 
blue nevi, thus simulating the clinical picture of a 
benign lesion [15]. All possible options of coexistence 
between melanocytic and keratinocyte tumours are 
most safely demonstrated histopathologically and 
immunohistochemically [15], [18], [20], [21]. 
Unlike collisional tumours, the simultaneous 
occurrence of two different primary histological 
carcinoma types is extremely rare [10], [11]. To our 
knowledge, we present for the first time in the world 
literature a unique case of a patient with simultaneous 
occurrence of three primary cutaneous tumours with 
different localisation – two keratinocyte tumours (2 
basal cell carcinomas) in combination with presternal 
localised superficial melanoma. 
Two cases of patients with BCC, SCC and 
MM have been documented in the world literature 
[10], [11]. In one case, the data simultaneously 
manifests the three types of tumours [10], and the 
other described case refers to a patient with 
metastatic melanoma in combination with 2 
keratinocyte tumours (BCC and SCC with different 
localisation) [11]. 
Patients with BCC, MM, SCC are at increased 
risk of development of subsequent cutaneous tumours 
of the same or another type [24], [25], [26]. Cutaneous 
melanoma diagnosis is considered a risk of 
developing multiple cutaneous (pre-) malignancies 
[25]. Patients with BCC may subsequently develop 
other forms of cancer, such as testicular cancer, 
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breast cancer, and non-Hodgkin lymphoma [27]. This 
requires their regular analysis (clinical and apparatus 
diagnostic procedures in the framework of selected 
screening programs). 
Basal cell carcinomas located in the so-called 
H-zone of the face (nasolabial fold, nasal alar, orbital 
area and auricular area, are considered to be high risk 
regarding the occurrence of possible recurrence [28]. 
High-risk cases substantially include long-
term tumors (not defined), localized midface/ear 
(basalioma adjacent to the lower eyelid/this criterion is 
met in our patient), diameter over 2 cm (basalioma in 
proximity to the lower eyelid/this criterion is met in our 
patient also), aggressive histological subtypes, 
perivascular/perineural infiltration, prior radiation 
therapy or other types of treatment failure [29]. 
Advanced BCCs are defined as III stage (with 
musculature infiltration, as described in our patient) or 
IV stage tumours, and when their size is more than 5 
cm, they are classified as giant BCC [29]. There is 
often a criteria overlap between the high-risk and 
advanced BCCs, as well as failure of the lesion to 
meet all the requirements specified in the definitions. 
Both types often require the application of 
more sophisticated surgical techniques [28], [30]. 
In conclusion, concomitant surgical treatment 
of risk basal cell carcinoma with facial muscular 
infiltration combined with cutaneous melanoma of 
presternal localisation and additional resection of 
basal cell carcinoma on the shoulder is a serious 
challenge for most of the dermatosurgeons. We at this 
moment inform for the first time in the world literature 
about the simultaneous diagnosis of 2 keratinocyte 
and one melanocytic tumour in the form of primaries 
with different localisation, as well as their successful 
surgical treatment within one surgical session. 
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